サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生体吸収性血管足場市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年から2031年
市場調査レポート
商品コード
1301437

生体吸収性血管足場市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年から2031年

Bioresorbable Vascular Scaffold Market (Product Type: Everolimus-eluting Device, Novolimus-eluting Device, Sirolimus-eluting Device, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 228 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
生体吸収性血管足場市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年から2031年
出版日: 2023年05月22日
発行: Transparency Market Research
ページ情報: 英文 228 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生体吸収性血管足場市場- レポートの範囲

世界の生体吸収性血管足場市場に関するTMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も掲載しています。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、生体吸収性血管足場市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書を参照することが含まれます。

このレポートは、世界の生体吸収性血管足場市場の競合情勢を詳しく掘り下げています。世界の生体吸収性血管足場市場で活動している主要プレーヤーが特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の生体吸収性血管足場市場のプレーヤーの属性です。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • 技術の進歩
  • 疾病の発生率と有病率
  • 規制分析
  • COVID-19の影響分析

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場価値予測：製品タイプ別、2017-2031
    • エベロリムス溶出装置
    • ノボリムス溶出装置
    • シロリムス溶出装置
    • その他（ラパマイシンなど）
  • 市場魅力分析：製品タイプ別

第7章 世界市場の分析と予測：疾患の種類別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場価値予測：疾患別、2017年～2031年
    • 冠動脈疾患
    • 末梢動脈疾患
  • 市場魅力分析：疾患別

第8章 世界市場の分析と予測：材料タイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場価値予測：素材別、2017年～2031年
    • ポリ-L-乳酸（PLLA）
    • チロシン由来ポリカーボネート
    • その他（ポリジオキサノンなど）
  • 市場魅力分析：素材別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場価値予測：エンドユーザー別、2017年～2031年
    • 病院
    • 外来手術センター
    • 心臓カテーテル検査室
    • その他（調査等）
  • 市場魅力分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場価値予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場企業- 競合マトリックス（企業の階層および規模別）
  • 企業別市場シェア分析（2021）
  • 企業プロファイル
    • Kyoto Medical Planning Co., Ltd.
    • BIOTRONIK Group of Companies
    • REVA Medical
    • Elixir Medical
    • Arterius
    • Meril Life Sciences Pvt. Ltd
    • S3V Vascular Technologies
    • Zorion medical
    • Medtronic（development phase）
図表

List of Tables

  • Table 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 03: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 04: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 09: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 10: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 14: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 15: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 19: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 20: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 24: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 25: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 28: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 29: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 30: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 03: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 04: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 05: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 06: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 07: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 08: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 09: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 10: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 11: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 12: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 13: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 14: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 15: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 16: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 17: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 18: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 19: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 20: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 21: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 22: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 23: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 25: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 26: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 27: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 28: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 29: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 30: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 31: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 32: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 38: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 39: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 40: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 41: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 42: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 43: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 44: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 46: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 48: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 49: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 50: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 51: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 52: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 53: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 54: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 55: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 56: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 57: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 59: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 60: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 61: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 62: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 63: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 64: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 65: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 66: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 67: Global Bioresorbable Vascular Scaffold Market Share Analysis, by Company, 2022
目次
Product Code: TMRGL32003

Bioresorbable Vascular Scaffold Market - Scope of Report

TMR's report on the global Bioresorbable Vascular Scaffold market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Bioresorbable Vascular Scaffold market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Bioresorbable Vascular Scaffold market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Bioresorbable Vascular Scaffold market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Bioresorbable Vascular Scaffold market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Bioresorbable Vascular Scaffold market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Bioresorbable Vascular Scaffold market.

The report delves into the competitive landscape of the global Bioresorbable Vascular Scaffold market. Key players operating in the global Bioresorbable Vascular Scaffold market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Bioresorbable Vascular Scaffold market profiled in this report.

Key Questions Answered in Global Bioresorbable Vascular Scaffold Market Report:

  • What is the sales/revenue generated by Bioresorbable Vascular Scaffold across all regions during the forecast period?
  • What are the opportunities in the global Bioresorbable Vascular Scaffold market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Bioresorbable Vascular Scaffold Market - Research Objectives and Research Approach

The comprehensive report on the global Bioresorbable Vascular Scaffold market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Bioresorbable Vascular Scaffold market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Bioresorbable Vascular Scaffold market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioresorbable Vascular Scaffold Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Development
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, 2017 - 2031

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Disease Incidence and Prevalence
  • 5.3. Regulatory Analysis
  • 5.4. COVID-19 Impact Analysis

6. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017 - 2031
    • 6.3.1. Everolimus-eluting Device
    • 6.3.2. Novolimus-eluting Device
    • 6.3.3. Sirolimus-eluting Device
    • 6.3.4. Others (Rapamycin, etc.)
  • 6.4. Market Attractiveness Analysis, By Product Type

7. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Disease Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 7.3.1. Coronary Artery Disease
    • 7.3.2. Peripheral Artery Disease
  • 7.4. Market Attractiveness Analysis, By Disease Type

8. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Material Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Material Type, 2017 - 2031
    • 8.3.1. Poly-L-Lactic Acid (PLLA)
    • 8.3.2. Tyrosine-derived Polycarbonate
    • 8.3.3. Others (Polydioxanone, etc.)
  • 8.4. Market Attractiveness Analysis, By Material Type

9. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017 - 2031
    • 9.3.1. Hospital
    • 9.3.2. Ambulatory Surgical Center
    • 9.3.3. Cardiac Catheterization Lab
    • 9.3.4. Others (Research Institute, etc.)
  • 9.4. Market Attractiveness Analysis, By End-user

10. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, By Region

11. North America Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 11.2.1. Everolimus-eluting Device
    • 11.2.2. Novolimus-eluting Device
    • 11.2.3. Sirolimus-eluting Device
    • 11.2.4. Others (Rapamycin, etc.)
  • 11.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 11.3.1. Coronary Artery Disease
    • 11.3.2. Peripheral Artery Disease
  • 11.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 11.4.1. Poly-L-Lactic Acid (PLLA)
    • 11.4.2. Tyrosine-derived Polycarbonate
    • 11.4.3. Others (Polydioxanone, etc.)
  • 11.5. Market Value Forecast, by End-user, 2017 - 2031
    • 11.5.1. Hospital
    • 11.5.2. Ambulatory Surgical Center
    • 11.5.3. Cardiac Catheterization Lab
    • 11.5.4. Others (Research Institute, etc.)
  • 11.6. Market Value Forecast, by Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Disease Type
    • 11.7.3. By Material Type
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 12.2.1. Everolimus-eluting Device
    • 12.2.2. Novolimus-eluting Device
    • 12.2.3. Sirolimus-eluting Device
    • 12.2.4. Others (Rapamycin, etc.)
  • 12.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 12.3.1. Coronary Artery Disease
    • 12.3.2. Peripheral Artery Disease
  • 12.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 12.4.1. Poly-L-Lactic Acid (PLLA)
    • 12.4.2. Tyrosine-derived Polycarbonate
    • 12.4.3. Others (Polydioxanone, etc.)
  • 12.5. Market Value Forecast, by End-user, 2017 - 2031
    • 12.5.1. Hospital
    • 12.5.2. Ambulatory Surgical Center
    • 12.5.3. Cardiac Catheterization Lab
    • 12.5.4. Others (Research Institute, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Disease Type
    • 12.7.3. By Material Type
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 13.2.1. Everolimus-eluting Device
    • 13.2.2. Novolimus-eluting Device
    • 13.2.3. Sirolimus-eluting Device
    • 13.2.4. Others (Rapamycin, etc.)
  • 13.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 13.3.1. Coronary Artery Disease
    • 13.3.2. Peripheral Artery Disease
  • 13.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 13.4.1. Poly-L-Lactic Acid (PLLA)
    • 13.4.2. Tyrosine-derived Polycarbonate
    • 13.4.3. Others (Polydioxanone, etc.)
  • 13.5. Market Value Forecast, by End-user, 2017 - 2031
    • 13.5.1. Hospital
    • 13.5.2. Ambulatory Surgical Center
    • 13.5.3. Cardiac Catheterization Lab
    • 13.5.4. Others (Research Institute, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Disease Type
    • 13.7.3. By Material Type
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 14.2.1. Everolimus-eluting Device
    • 14.2.2. Novolimus-eluting Device
    • 14.2.3. Sirolimus-eluting Device
    • 14.2.4. Others (Rapamycin, etc.)
  • 14.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 14.3.1. Coronary Artery Disease
    • 14.3.2. Peripheral Artery Disease
  • 14.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 14.4.1. Poly-L-Lactic Acid (PLLA)
    • 14.4.2. Tyrosine-derived Polycarbonate
    • 14.4.3. Others (Polydioxanone, etc.)
  • 14.5. Market Value Forecast, by End-user, 2017 - 2031
    • 14.5.1. Hospital
    • 14.5.2. Ambulatory Surgical Center
    • 14.5.3. Cardiac Catheterization Lab
    • 14.5.4. Others (Research Institute, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Disease Type
    • 14.7.3. By Material Type
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 15.2.1. Everolimus-eluting Device
    • 15.2.2. Novolimus-eluting Device
    • 15.2.3. Sirolimus-eluting Device
    • 15.2.4. Others (Rapamycin, etc.)
  • 15.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 15.3.1. Coronary Artery Disease
    • 15.3.2. Peripheral Artery Disease
  • 15.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 15.4.1. Poly-L-Lactic Acid (PLLA)
    • 15.4.2. Tyrosine-derived Polycarbonate
    • 15.4.3. Others (Polydioxanone, etc.)
  • 15.5. Market Value Forecast, by End-user, 2017 - 2031
    • 15.5.1. Hospital
    • 15.5.2. Ambulatory Surgical Center
    • 15.5.3. Cardiac Catheterization Lab
    • 15.5.4. Others (Research Institute, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Disease Type
    • 15.7.3. By Material Type
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. Kyoto Medical Planning Co., Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Test Type Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. BIOTRONIK Group of Companies
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Test Type Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. REVA Medical
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Test Type Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Elixir Medical
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Test Type Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Arterius
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Test Type Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Meril Life Sciences Pvt. Ltd
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Test Type Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. S3V Vascular Technologies
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Test Type Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Zorion medical
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Test Type Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Medtronic (development phase)
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Test Type Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview